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NOVELTY AND IMPACT OF THE WORK: 
This large prospective cohort supports positive and inverse associations of total 
energy intake and dietary polyunsaturated fat intake respectively with 
differentiated thyroid carcinoma risk. However, the associations with 
carbohydrate-related variables were heterogeneous across BMI groups, 





Incidence rates of differentiated thyroid carcinoma (TC) have increased in many 2 
countries. Adiposity and dietary risk factors may play a role, but little is known 3 
on the influence of energy intake and macronutrient composition. The aim of 4 
this study is to investigate associations between TC and the intake of energy, 5 
macronutrients, glycemic index (GI) and glycemic load in the European 6 
Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The study 7 
included 477,274 middle-age participants (70.2% women) from 10 European 8 
countries. Dietary data were collected using country-specific validated dietary 9 
questionnaires. Total carbohydrates, proteins, fats, saturated, monounsaturated 10 
and polyunsaturated fats (PUFA), starch, sugar, fiber and glycemic load were 11 
computed as g/1000kcal. Multivariable Cox regression was used to calculate 12 
multivariable adjusted hazard ratios (HR) and 95% confidence interval (CI) by 13 
intake quartile (Q). After a mean follow-up time of 11 years, differentiated TC 14 
was diagnosed in 556 participants (90% women). Overall, we only found 15 
significant associations with total energy (HRQ4vsQ1 1.29; 95% CI 1.00-1.68) and 16 
PUFA intakes (HRQ4vsQ1 0.74, 95% CI 0.57-0.95). However, the associations 17 
with starch and sugar intake and GI were significantly heterogeneous across 18 
BMI groups, i.e., positive associations with starch and GI were found in 19 
participants with a body mass index (BMI) ≥25 and with sugar intake in those 20 
with BMI <25. Moreover, inverse associations with starch and GI were observed 21 
in subjects with BMI<25. In conclusion, our results suggest that high total 22 
energy and low PUFA intakes may increase the risk of differentiated TC. 23 
Positive associations with starch intake and GI in participants with BMI ≥25 24 
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suggest that those persons may have a greater insulin response to high starch 25 




Thyroid carcinoma (TC) is the most common endocrine cancer and its incidence 28 
has steadily increased in the last three decades in many countries.1,2 Upward 29 
trends of differentiated TC, by far the most common type of TC, are clearly 30 
correlated with the introduction of ultrasonography and other imaging 31 
techniques since the late 1970s and the use of fine-needle biopsies for 32 
assessment of thyroid nodules. However, a role of lifestyle factors, including 33 
dietary habits, and environmental exposures is possible and ill-understood.1 34 
The only well-established TC risk factors are ionizing radiation,3 benign thyroid 35 
disease,4 and high body mass (including weight and height).5,6 Although thyroid 36 
nodules and well-differentiated TC are more often detected in women than men, 37 
the associations with individual reproductive and menstrual factors and female 38 
hormone use are, if anything, weak.7 39 
Dietary factors including some food groups (fish, shellfish, meat, starchy foods, 40 
fruits, and vegetables),8,9 macro-nutrients,10 vitamins, micro-elements (iodine, 41 
nitrate, nitrites),8,11-13 glycemic index (GI) and load (GL),14 and local traditional 42 
dietary patterns (Polynesian dietary pattern)15,16 have been studied in respect to 43 
TC risk. However, findings were mainly based on case-control studies and are 44 
inconclusive.8,9 Chronic iodine deficiency is the only dietary recognized risk 45 
factor for goiter and follicular TC.8 46 
The aim of the current study is to evaluate prospectively the relationships 47 
between total energy intake, macronutrient composition (including sugar, starch, 48 
fiber and fats), GI and GL and the risk of developing differentiated TC in a large 49 
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European cohort: the European Prospective Investigation into Cancer and 50 
Nutrition (EPIC) study. 51 
MATERIAL AND METHODS 52 
Study Population. EPIC is a multi-center, prospective cohort that was 53 
designed to study the role of dietary and environmental factors in the risk of 54 
developing cancer. Details on the EPIC study have been published 55 
previously.17,18 Briefly, a total of 521,330 subjects (70.6% women) aged mainly 56 
35–70 years were recruited between 1992 and 2000, primarily from the general 57 
population, in 23 centers from 10 western European countries. All participants 58 
gave written informed consent and the project was approved by ethical review 59 
boards of the International Agency for Research on Cancer and local 60 
participating centers. 61 
Dietary and Lifestyle Data. Data collection includes participants’ habitual 62 
dietary intake during the year prior to recruitment using country-specific 63 
validated dietary questionnaires.18,19 Total energy and macronutrient intakes 64 
were estimated by using the standardized EPIC Nutrient Database.20 65 
Carbohydrates are calculated as the sum of all “available carbohydrates” 66 
(sugars, oligosaccharides and starch) and do not include fibers. Both dietary GI 67 
and GL were estimated as previously described.21 Briefly, the average dietary 68 
GI for each subject was calculated as the sum of the GIs of each food item 69 
consumed, multiplied by the average daily amount consumed and the 70 
percentage of carbohydrate content, all divided by the total daily carbohydrate 71 
intake. The GL was calculated similarly except that there was no division by 72 
total carbohydrate intake. Each unit of GL is equivalent to the blood glucose-73 
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raising effect of consuming 1 g of glucose. At baseline, information on socio-74 
demographic characteristics, tobacco consumption, physical activity according 75 
to the Cambridge Physical Activity Index,22 education, and medical history was 76 
self-reported using standardized lifestyle questionnaires.18,22 In most centers, 77 
weight and height at recruitment were measured; except for Oxford-UK, France, 78 
and Norway, where self-reported anthropometric values were collected. 79 
Follow-up and case ascertainment. Incident cancer cases and deaths were 80 
identified through population-based cancer registries and mortality registries or 81 
active follow-up, depending on the center. Censoring dates for the last complete 82 
follow-up ranged from December 2006 to December 2009, depending on the 83 
study center. Cases were defined as subjects with a first primary TC (code C73 84 
according to the International Classification of Diseases, ICD-10) during follow-85 
up.  86 
Of 604 TC cases, anaplastic (n=6), medullary (n=28) and TC defined as 87 
lymphoma (n=1), or ‘‘other morphologies’’ (n=3) were excluded. We also 88 
excluded 28,151 participants (including 1 differentiated TC case) with prevalent 89 
cancer other than non-melanoma skin cancer, and 15,867 participants 90 
(including 9 differentiated TC cases) for whom dietary information was 91 
unavailable or considered to be implausible, i.e., participants who were in the 92 
top or the bottom 1% of the distribution of the ratio of total energy intake to 93 
energy requirement.23 A total of 477,274 men and women and 5,262,772 94 
person-years of observation (mean follow-up time of 11 years) were included in 95 
the present analysis. A total of 556 primary differentiated TC cases were 96 
retained for the present report including 435 papillary, 76 follicular, and 45 not 97 
otherwise specified TC, most likely to be also papillary TC. 98 
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Statistical analysis. Total energy intake was included in the models as 99 
kcal/day. Carbohydrate, lipids, protein, saturated, monounsaturated and 100 
polyunsaturated fats (PUFA), sugar, starch and fiber intakes were computed as 101 
energy density (g/1000kcal) per day. GL was calculated as units/1000kcal per 102 
day, while GI was computed as units/day (since GI values reflect the 103 
physiological response to the consumption of the food item, but not its quantity). 104 
Cox proportional hazards models were used to calculate hazard ratios (HR) and 105 
95% confidence intervals (95% CI) for the intake of all dietary exposures of 106 
interest in relation to differentiated TC risk. Tests and graphs based on 107 
Schoenfeld residuals were used to assess proportional hazards assumptions, 108 
which were satisfied. Age was used as primary dependent time variable, with 109 
entry time defined as the subject’s age at recruitment and exit time as age at 110 
differentiated TC diagnosis, death or censoring date (lost or end of follow-up), 111 
whichever occurred first. Model 1 was stratified by sex, age at recruitment (1-112 
year intervals), and center. Model 2 was additionally adjusted for body mass 113 
index (BMI, kg/m2), smoking status (never, former, current smoker, and 114 
unknown), education level (primary, secondary, and unknown), physical activity 115 
(inactive, active, and unknown), total energy (kcal/d) except when total energy 116 
is the main exposure, and alcohol intake (g/d). In women Model 2 also included 117 
menopause status, type of menopause (pre-, peri-, post-menopausal, surgical 118 
menopause).7 Oral contraceptive use (yes, no, and unknown) and history of 119 
infertility problems (yes, no, and unknown) were not included in final models 120 
because they did not change effect estimates by more 10%. In a secondary 121 
analysis, model 2 was mutually adjusted, when appropriate, for protein, 122 
saturated, monounsaturated and polyunsaturated fats, sugar, starch and fiber 123 
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intakes (g/d). Dietary exposures were assessed by cohort-wide quartiles or 124 
BMI-, age-, or sex-specific quartile in stratified analyses. Tests for linear trend 125 
were performed by assigning the medians of each quartile as scores. Separate 126 
analyses were performed for papillary TC and strata of BMI, waist 127 
circumference, sex and age. Possible interactions with sex, age (<50 vs. ≥50 128 
years), BMI (<25 vs. ≥25kg/m2), waist circumference (≤88 vs. >88 in women 129 
and ≤102 vs. >102cm in men), physical activity index and smoking status were 130 
examined by including the interaction terms in the most adjusted models. 131 
Interactions were tested to evaluate whether separate analyses, stratified 132 
according to each variable, were required. The Wald test was used to evaluate 133 
the heterogeneity of risk trends across sex, age, BMI or waist circumference 134 
strata. Three types of sensitivity analyses were performed by excluding them 135 
from the analyses: 1) 67,378 women from the French component of EPIC (202 136 
cases of differentiated TC ), since French women represented the 40.5% of TC 137 
cases in women; 2) 14,856 participants who had diabetes or unknown diabetes 138 
status at baseline (11 cases of differentiated TC), because diabetes is a 139 
potential risk factor of TC; and 3) 81 cases in whom differentiated TC was 140 
diagnosed in the first 2 years of follow-up, because some participants may have 141 
modified their diet during the early prediagnostic period of the disease. We 142 
considered 2-tailed P-values ≤0.05 to be statistically significant. Statistical 143 
analyses were conducted using SAS, version 9.3, software (SAS Institute, Inc., 144 
Cary, North Carolina). 145 
RESULTS 146 
Baseline characteristics of participants with and without differentiated TC are 147 
shown in Table 1. Cases were predominantly women (89.7%) and median age 148 
14 
 
at baseline was 50.0 among women and 51.7 among men. Median BMI, alcohol 149 
intake, percentages of never-smokers, secondary education, physical inactivity, 150 
and diabetes did not differ by case status. More female cases than non-cases 151 
were peri-menopausal or had undergone surgical menopause (Table 1). 152 
Table 2 shows the relationship between differentiated TC risk and energy 153 
intake, energy density of various macronutrients, and GI and GL. Total energy 154 
intake was borderline positively associated with differentiated TC risk in Model 2 155 
analyses [HRQ4vsQ1 1.29, 95% CI 1.00-1.68; P-trend = 0.06]. A significantly 156 
inverse association with PUFA intake was also found in Model 2 analyses (HR 157 
Q4vsQ1 0.74, 95% CI 0.57-0.95; P-trend = 0.028) (Table 2). In models mutually 158 
adjusted, results were similar to HRs observed in model 2 but with wider 95% 159 
CI, especially for PUFA where the inverse associations became not significant 160 
(HR Q4vsQ1 0.73, 95% CI 0.49-1.08; P-trend = 0.15). No significant associations 161 
were observed with energy density of carbohydrates, fat, saturated and 162 
monounsaturated fats, protein, starch, sugar, fiber, and GI and GL in either 163 
model. Similar HRs were found in analyses restricted to papillary TC 164 
(Supplemental table 1).  165 
The interactions between BMI group and the intake of starch, sugar, and GI 166 
were statistically significant (P-value for interaction = 0.032, 0.025, and 0.011, 167 
respectively), and therefore BMI-stratified Model 2 analyses were performed for 168 
carbohydrate-related nutrients, fiber, and GI and GL (Table 3). Significant 169 
positive associations were observed for starch intake (HRQ4vsQ1 1.52, 95% CI 170 
1.02-2.28; P-trend = 0.020) and GI (HRQ4vsQ1 1.54, 95% CI 1.05-2.28; P-trend = 171 
0.014) among participants with BMI ≥25. Conversely, in participants with BMI 172 
<25 starch intake (HRQ4vsQ1 0.64, 95% CI 046-0.89; P-trend = 0.003) and GI 173 
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(HRQ4vsQ1 0.64, 95% CI 0.46-0.89; P-trend = 0.003) were inversely associated 174 
with differentiated TC risk and sugar intake was positively associated (HRQ4vsQ1 175 
1.61, 95% CI 1.16-2.24; P-trend = 0.002). Similar associations were observed 176 
after stratifying by waist circumference (data not shown). 177 
In a separate analysis by sex, a significant positive association was detected 178 
with total carbohydrate intake in men (HRQ4vsQ1 4.15, 95% CI 1.37-15.22; P-179 
trend = 0.019) (Supplemental table 1).  The  interaction between carbohydrate 180 
intake and TC risk by sex was statistically significant (P-value for interaction = 181 
0.022). In a separate analysis by age groups (<50y vs. ≥50y), similar results as 182 
the entire cohort were found, highlighting the significant inverse association with 183 
PUFA in older subjects (HRQ4vsQ1 0.63, 95% CI 0.44-0.92; P-trend = 0.024) 184 
(Supplemental table 1). No statistically significant interactions of dietary habits 185 
with smoking status or physical activity level were observed. 186 
Results similar to those of Table 2 and 3 were observed in sensitivity analyses 187 
in which the French EPIC component, participants with diabetes, and TC cases 188 
who had been diagnosed within the first 2 years of follow-up were excluded 189 
(data not shown). 190 
DISCUSSION 191 
The current large European prospective cohort study suggests that high total 192 
energy and low PUFA intakes may increase the risk of differentiated TC. Among 193 
all study participants, the intake of carbohydrates, proteins, and fat were not 194 
related to differentiated TC risk. However, positive associations with starch 195 
intake, and GI were statistically significant among persons with BMI≥25 and 196 
statistically heterogeneous from findings in leaner persons. Conversely, a 197 
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positive association with sugar intake was found among subjects with BMI<25 198 
and was statistically heterogeneous from findings in persons with BMI≥25. No 199 
differences in TC risk by intake of proteins, fat, or fiber were found in either 200 
overall analyses or in analyses stratified by BMI, sex, or age group. Although 201 
the large increases in the incidence of very seldom fatal differentiated TC is 202 
attributed to the increased surveillance of the thyroid gland and the advent of 203 
more sensitive diagnostic methods,24 increases in overweight, insulin 204 
resistance, and refined carbohydrate intake over the last 20 years may have 205 
played a role. 206 
Very little information is available on the relationship between TC risk and the 207 
intake of energy and main energy sources. Case-control studies from Brazil,10 208 
Italy,25 and Poland26 showed that higher intake of energy, and rich-carbohydrate 209 
sources among TC cases as compared to controls. In a case-control study from 210 
French Polynesia, bread, rice and pasta were included in a “Western dietary 211 
pattern” that was also positively associated with elevated risk of differentiated 212 
TC.15 Positive associations with elevated GI and GL were reported from Italy.14 213 
GI and GL are indicators of the physiological response to different foods in 214 
terms of plasma glucose and insulin response27 and are highly correlated with 215 
high intake of refined carbohydrates.  216 
Our results raise the possibility that BMI may be a modifier of the association of 217 
high-energy and high-GI diet with the risk of differentiated TC. Overweight is a 218 
major determinant of insulin resistance and hyperinsulinemia,28 which were 219 
associated with a higher prevalence of differentiated TC.29 Our results may 220 
therefore point to a stronger insulin response to diet in individuals with BMI≥25 221 
than in those with BMI<25 which may affect TC risk. The findings on sugar 222 
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seem to be contradictory as the adverse effect of high intake is restricted to 223 
subjects with BMI<25. Individuals with overweight may voluntarily reduce their 224 
sugar intake, as suggested by the slightly lower sugar intake in subjects with 225 
BMI≥25 compared to those with BMI<25 (Table 3). Under-reporting of sugar 226 
intake among over-weight people is also possible. 227 
Hyperglycemia, insulin resistance, and obesity increase oxidative stress and 228 
stimulate mitogenic pathways of follicular thyroid cells.30 The growth-promoting 229 
effect of insulin and insulin-like growth factor-I (IGF-I) have also been proposed 230 
as a causal link between abnormal glucose metabolism and cancer risk and 231 
doubling in IGF-I concentration is associated with a relative risk of 1.48 (95% 232 
CI: 1.06–2.08) for differentiated TC in the EPIC study.31 Moreover, a recent 233 
meta-analysis showed that subjects with diabetes have a higher risk for TC, 234 
particularly women.32 High blood glucose levels were also associated with a 235 
higher prevalence of thyroid nodules and TC in Chinese studies.33,34 However, 236 
in a European cohort study, blood glucose level was associated with a 237 
significantly decreased risk of incident TC35 and no association between fasting 238 
serum insulin and TC in both genders was observed in a screening program of 239 
TC in the Republic of Korea.36 240 
Our findings on total energy intake need to be interpreted with caution as 241 
energy intake and energy expenditure are crudely measured.37 Obviously, diets 242 
high in energy and starch can increase the risk of having larger waist 243 
circumference and developing overweight and obesity that are associated with 244 
differentiated TC risk.5,6 In fact, energy intake at baseline was marginally larger 245 
in participants with BMI≥25 than in those with BMI<25 (Table 3), possibly 246 
reflecting a gradual gain in weight.  247 
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In respect to fat intake, our study shows an inverse association between PUFA 248 
intake and differentiated TC risk in agreement with a Norwegian case-control 249 
study in which high serum levels of PUFA, particularly arachidonic and 250 
docosahexaenoic acids, were associated with a reduced TC risk.38 Moreover, 251 
two case-control studies found significantly lower urinary or serum levels of 252 
PUFA in TC cases than in controls.39,40 In EPIC, the main food sources of PUFA 253 
intake are vegetable oils, nuts and seeds, and fish.41 Vegetable oils and 254 
especially nuts and seeds are rich in polyphenols that are well-known for having 255 
several anticarcinogenic effects and have been inversely associated with TC 256 
risk in a large cohort study.13 The influence of fish consumption on TC risk has 257 
been investigated in numerous studies,42 as salt-water fish is a major source of 258 
dietary iodine. However, results are not conclusive.8,9 259 
Strengths of the present study include the prospective design, the 260 
completeness of follow-up and dietary questionnaire, and the inclusion of 261 
participants from cohorts across 10 European countries with widely varying 262 
dietary habits. Our analyses were adjusted for a comprehensive range of 263 
potential confounders, including alcohol drinking that shows an inverse 264 
association with TC risk.9 Obviously, measurement errors in the dietary 265 
questionnaire may have attenuated our dietary findings or left residual 266 
confounding effects from total energy and physical activity levels. Modification 267 
of diet in the years prior to a diagnosis of differentiated TC is unlikely and the 268 
exclusion of cases diagnosed in the first two years of follow-up did not alter our 269 
findings. Diabetics were not overrepresented among TC cases and, again, the 270 




In conclusion, this large prospective study suggests a direct association 273 
between differentiated TC risk and total energy intake and an inverse 274 
association with dietary PUFA intake. Positive associations with starch intake 275 
and GI, but not sugar, in subjects with BMI ≥25 encourages further study of the 276 
combined influence of diet, BMI, insulin resistance, and related serum markers.  277 
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Supplementary table 1. Hazard ratios (HR) and 95% confidence intervals for 
differentiated thyroid carcinoma stratified by sex and age according to group-
specific quartiles of intake of total energy, macronutrients, glycemic index and 
load in the EPIC study. 
 
Model 2: Cox model stratified by center, age at baseline and sex (when 
appropriate), and adjusted for body mass index, smoking status, education, 




Model 2 Model 2 Model 2 Model 2 Model 2
Intake HR (95% CI) Intake HR (95% CI) Intake HR (95% CI) Intake HR (95% CI) Intake HR (95% CI)
Total energy (kcal/d)
Quartile 1 <1,630 97 1 (ref) <1,546 102 1 (ref) <1,938 17 1 (ref) <1,636 60 1 (ref) <1,626 68 1 (ref)
Quartile 2 1,630‐1,995 113 1.16 (0.88‐1.52) 1,546‐1,870 102 0.95 (0.72‐1.26) 1,938‐2,344 11 0.53 (0.24‐1.14) 1,636‐2,008 72 1.11 (0.78‐1.57) 1,626‐1,986 73 1.12 (0.80‐1.57)
Quartile 3 1,996‐2,435 107 1.10 (0.83‐1.47) 1,871‐2,252 126 1.10 (0.84‐1.45) 2,345‐2,808 18 0.86 (0.43‐1.72) 2,009‐2,464 68 1.03 (0.71‐1.48) 1,987‐2,414 70 1.19 (0.85‐1.68)
Quartile 4 >2,435 118 1.32 (0.99‐1.77) >2,252 169 1.25 (0.96‐1.63) >2,808 11 0.49 (0.22‐1.11) >2,464 76 1.31 (0.91‐1.89) >2,414 69 1.26 (0.87‐1.82)
P‐trend 0.08 0.038 0.19 0.17 0.21
Carbohydrates (g/1000kcal*d)
Quartile 1 <98.6 113 1 (ref) <100.2 145 1 (ref) <95.1 6 1 (ref) <99.3 74 1 (ref) <98.1 66 1 (ref)
Quartile 2 98.6‐110.6 116 1.09 (0.83‐1.42) 100.2‐111.9 142 1.10 (0.87‐1.41) 95.1‐107.2 15 2.79 (1.02‐7.62) 99.3‐111.5 93 1.28 (0.93‐1.77) 98.1‐109.9 61 0.88 (0.62‐1.24)
Quartile 3 110.7‐122.4 115 1.16 (0.87‐1.53) 112.0‐123.4 111 0.95 (0.73‐1.24) 107.3‐119.8 15 3.03 (1.05‐8.75) 111.6‐123.1 61 1.03 (0.72‐1.48) 110.0‐121.9 79 1.06 (0.75‐1.51)
Quartile 4 >122.4 91 1.02 (0.75‐1.39) >123.4 101 0.97 (0.73‐1.29) >119.8 21 4.15 (1.37‐15.22) >123.1 48 0.99 (0.66‐1.48) >121.9 74 1.03 (0.71‐1.49)
P‐trend 0.78 0.65 0.019 0.78 0.68
Protein (g/1000kcal*d)
Quartile 1 <37.0 82 1 (ref) <37.7 108 1 (ref) <35.5 13 1 (ref) <36.4 46 1 (ref) <37.4 59 1 (ref)
Quartile 2 37.0‐41.6 104 1.01 (0.75‐1.36) 37.7‐42.4 124 1.03 (0.79‐1.35) 35.5‐39.8 18 1.19 (0.57‐2.49) 36.4‐41.1 64 1.15 (0.79‐1.66) 37.4‐42.0 67 1.16 (0.81‐1.68)
Quartile 3 41.7‐46.9 123 1.04 (0.77‐1.40) 42.5‐47.7 129 1.02 (0.77‐1.34) 39.9‐44.8 15 1.02 (0.46‐2.25) 41.2‐46.4 87 1.03 (0.70‐1.52) 42.1‐47.2 75 1.15 (0.79‐1.67)
Quartile 4 >46.9 126 1.02 (0.74‐1.39) >47.7 138 1.11 (0.84‐1.48) >44.8 11 0.92 (0.37‐2.29) >46.4 79 0.99 (0.66‐1.49) >47.2 79 1.29 (0.88‐1.91)
P‐trend 0.91 0.47 0.78 0.75 0.22
Fat (g/1000kcal*d)
Quartile 1 <34.4 79 1 (ref) <34.5 92 1 (ref) <34.2 17 1 (ref) <34.9 43 1 (ref) <34.1 62 1 (ref)
Quartile 2 34.4‐38.8 118 1.24 (0.93‐1.65) 34.5‐38.9 119 1.06 (0.81‐1.40) 34.2‐38.6 15 0.94 (0.46‐1.94) 34.9‐39.2 64 1.11 (0.74‐1.66) 34.1‐38.5 72 1.04 (0.74‐1.45)
Quartile 3 38.9‐43.3 112 1.03 (0.76‐1.38) 38.9‐43.4 142 1.11 (0.85‐1.46) 38.7‐43.1 14 0.82 (0.39‐1.76) 39.3‐43.7 85 1.23 (0.84‐1.82) 38.6‐43.0 80 0.94 (0.67‐1.33)
Quartile 4 >43.3 126 0.96 (0.71‐1.30) >43.4 146 0.96 (0.72‐1.27) >43.1 11 0.55 (0.22‐1.38) >43.7 84 1.13 (0.76‐1.69) >43.0 66 0.73 (0.50‐1.06)
P‐trend 0.43 0.72 0.21 0.56 0.07
Saturated fats (g/1000kcal*d)
Quartile 1 <12.5 89 1 (ref) <12.6 103 1 (ref) <12.1 16 1 (ref) <12.5 53 1 (ref) <12.5 63 1 (ref)
Quartile 2 12.5‐14.7 90 0.92 (0.68‐1.25) 12.6‐14.8 102 0.94 (0.71‐1.25) 12.1‐14.4 14 1.06 (0.49‐2.28) 12.5‐14.7 64 1.19 (0.81‐1.73) 12.5‐14.7 49 0.72 (0.49‐1.06)
Quartile 3 14.8‐17.1 136 1.29 (0.97‐1.72) 14.9‐17.2 148 1.26 (0.96‐1.64) 14.5‐16.9 19 1.47 (0.67‐3.23) 14.8‐17.1 75 1.30 (0.89‐1.90) 14.8‐17.1 94 1.27 (0.90‐1.79)
Quartile 4 >17.1 120 0.95 (0.70‐1.30) >17.2 146 1.05 (0.79‐1.39) >16.9 8 0.59 (0.22‐1.62) >17.1 84 1.19 (0.80‐1.77) >17.1 74 0.86 (0.59‐1.25)
P‐trend 0.93 0.49 0.49 0.43 0.92
Monounsaturated fats (g/1000kcal*d)
Quartile 1 <11.6 83 1 (ref) <11.4 92 1 (ref) <12.0 9 1 (ref) <11.7 42 1 (ref) <11.5 59 1 (ref)
Quartile 2 11.6‐13.4 104 1.04 (0.77‐1.39) 11.4‐13.2 111 0.95 (0.72‐1.26) 12.0‐13.9 12 1.19 (0.49‐2.90) 11.7‐13.6 68 1.03 (0.68‐1.54) 11.5‐13.3 71 1.08 (0.77‐1.51)
Quartile 3 13.5‐16.0 126 1.06 (0.79‐1.41) 13.3‐15.7 147 1.02 (0.78‐1.34) 14.0‐16.5 17 1.43 (0.60‐3.40) 13.7‐16.4 80 1.27 (0.86‐1.87) 13.4‐15.7 81 0.95 (0.67‐1.35)
Quartile 4 >16.0 122 0.85 (0.61‐1.20) >15.7 149 0.84 (0.62‐1.16) >16.5 19 1.25 (0.47‐3.39) >16.4 86 1.02 (0.65‐1.59) >15.7 69 0.82 (0.54‐1.24)
P‐trend 0.30 0.31 0.69 0.93 0.25
Polyunsaturated fats (g/1000kcal*d)
Quartile 1 <4.9 116 1 (ref) <5.0 144 1 (ref) <4.7 20 1 (ref) >5.0 78 1 (ref) >4.8 81 1 (ref)
Quartile 2 4.9‐6.0 104 0.90 (0.68‐1.19) 5.0‐6.1 121 0.85 (0.66‐1.09) 4.7‐5.7 13 0.87 (0.41‐1.86) 5.0‐6.2 68 0.89 (0.63‐1.26) 4.8‐5.9 66 0.79 (0.57‐1.11)
Quartile 3 6.1‐7.6 109 0.90 (0.68‐1.20) 6.2‐7.7 121 0.82 (0.63‐1.06) 5.8‐7.3 14 1.07 (0.48‐2.39) 6.3‐7.8 66 0.75 (0.52‐1.08) 6.0‐7.4 69 0.81 (0.58‐1.14)
Quartile 4 >7.6 106 0.83 (0.62‐1.12) >7.7 113 0.75 (0.57‐0.98) >7.3 10 0.72 (0.29‐1.77) >7.8 64 0.84 (0.59‐1.20) >7.4 64 0.63 (0.44‐0.92)
P‐trend 0.26 0.046 0.52 0.38 0.024
Starch (g/1000kcal*d)
Quartile 1 <47.9 105 1 (ref) <47.9 132 1 (ref) <47.9 8 1 (ref) <49.4 76 1 (ref) <46.9 70 1 (ref)
Quartile 2 47.9‐57.2 102 1.08 (0.82‐1.42) 47.9‐57.1 124 1.03 (0.80‐1.32) 47.9‐57.3 15 1.98 (0.81‐4.79) 49.4‐59.2 79 1.16 (0.82‐1.65) 46.9‐55.8 69 1.03 (0.74‐1.42)
Quartile 3 57.3‐67.8 123 1.25 (0.96‐1.64) 57.2‐67.6 131 1.06 (0.82‐1.36) 57.3‐68.4 15 1.82 (0.72‐4.58) 59.3‐69.9 70 1.32 (0.94‐1.86) 55.9‐66.1 65 0.88 (0.63‐1.25)
Quartile 4 >67.8 105 1.00 (0.75‐1.35) >67.6 112 0.85 (0.64‐1.11) >68.4 19 1.71 (0.63‐4.64) >69.9 51 0.86 (0.58‐1.27) >66.1 76 0.96 (0.67‐1.37)
P‐trend 0.80 0.27 0.46 0.54 0.67
Sugar (g/1000kcal*d)
Quartile 1 <38.9 115 1 (ref) <40.8 150 1 (ref) <35.0 14 1 (ref) <38.6 78 1 (ref) <39.2 60 1 (ref)
Quartile 2 38.9‐48.4 104 0.85 (0.65‐1.11) 40.8‐50.0 112 0.80 (0.62‐1.02) 35.0‐44.3 16 1.19 (0.58‐2.47) 38.6‐47.9 68 0.78 (0.56‐1.08) 39.2‐48.8 70 1.04 (0.73‐1.48)
Quartile 3 48.5‐59.4 117 1.03 (0.79‐1.35) 50.1‐60.7 127 1.00 (0.78‐1.28) 44.4‐55.6 11 0.96 (0.42‐2.18) 48.0‐58.7 70 0.98 (0.70‐1.36) 48.9‐60.0 74 1.05 (0.73‐1.50)
Quartile 4 >59.4 99 1.05 (0.78‐1.41) >60.7 110 1.02 (0.78‐1.34) >55.6 16 1.72 (0.77‐3.87) >58.7 60 0.99 (0.68‐1.44) >60.0 76 1.25 (0.87‐1.81)
P‐trend 0.48 0.57 0.25 0.81 0.21
Fiber (g/1000kcal*d)
Quartile 1 <9.1 112 1 (ref) <9.5 150 1 (ref) <8.2 12 1 (ref) <9.0 71 1 (ref) <9.2 75 1 (ref)
Quartile 2 9.1‐10.8 109 0.83 (0.64‐1.09) 9.5‐11.3 130 0.89 (0.70‐1.13) 8.2‐9.9 16 1.21 (0.56‐2.63) 9.0‐10.6 65 0.78 (0.55‐1.09) 9.2‐11.0 70 0.78 (0.56‐1.10)
Quartile 3 10.9‐13.0 127 1.07 (0.81‐1.40) 11.4‐13.4 127 1.01 (0.79‐1.30) 10.0‐11.8 17 1.39 (0.62‐3.09) 10.7‐12.8 85 1.14 (0.82‐1.59) 11.1‐13.1 67 0.82 (0.57‐1.16)
Quartile 4 >13.0 87 0.83 (0.61‐1.14) >13.4 92 0.87 (0.65‐1.16) >11.8 12 1.10 (0.44‐2.73) >12.8 55 0.77 (0.51‐1.15) >13.1 68 0.86 (0.59‐1.25)
P‐trend 0.50 0.54 0.81 0.51 0.59
Glycemic index (unit/d)
Quartile 1 <53.6 120 1 (ref) <53.3 138 1 (ref) <54.5 12 1 (ref) <53.8 86 1 (ref) <53.6 85 1 (ref)
Quartile 2 53.6‐56.0 117 1.24 (0.96‐1.60) 53.3‐55.7 131 1.13 (0.89‐1.44) 54.5‐56.6 22 1.96 (0.96‐4.01) 53.8‐56.2 71 1.15 (0.84‐1.58) 53.6‐55.9 66 1.03 (0.75‐1.42)
Quartile 3 56.1‐58.5 90 0.98 (0.74‐1.30) 55.8‐58.3 101 0.89 (0.68‐1.16) 56.7‐59.0 12 1.16 (0.51‐2.64) 56.3‐58.7 58 0.85 (0.59‐1.20) 56.0‐58.4 61 1.02 (0.72‐1.43)
Quartile 4 >58.5 108 1.07 (0.81‐1.41) >58.3 129 1.00 (0.77‐1.29) >59.0 11 0.89 (0.35‐2.23) >58.7 61 0.84 (0.59‐1.20) >58.4 68 1.04 (0.73‐1.48)
P‐trend 0.91 0.72 0.65 0.20 0.84
Glycemic load (unit/1000kcal*d)
Quartile 1 <54.4 114 1 (ref) <54.9 122 1 (ref) <53.2 17 1 (ref) <54.9 77 1 (ref) <54.0 73 1 (ref)
Quartile 2 54.4‐61.9 117 1.01 (0.78‐1.32) 54.9‐62.4 110 0.93 (0.73‐1.18) 53.2‐60.7 11 1.18 (0.49‐2.86) 54.9‐62.7 74 1.23 (0.89‐1.68) 54.0‐61.3 67 0.75 (0.53‐1.07)
Quartile 3 62.0‐69.6 95 1.09 (0.82‐1.43) 62.5‐69.9 124 0.92 (0.71‐1.19) 60.8‐68.7 13 1.74 (0.72‐4.21) 62.8‐70.3 64 0.92 (0.65‐1.32) 61.4‐69.0 65 1.04 (0.75‐1.46)
Quartile 4 >69.6 109 0.98 (0.73‐1.32) >69.9 143 0.91 (0.69‐1.20) >68.7 16 1.95 (0.76‐5.03) >70.3 61 0.89 (0.60‐1.30) >69.0 75 1.01 (0.71‐1.44)










Quartile 1 <1,630 97 1 (ref) <1,546
Quartile 2 1,630‐1,995 113 1.16 (0.88‐1.52) 1,546‐1,870
Quartile 3 1,996‐2,435 107 1.10 (0.83‐1.47) 1,871‐2,252
Quartile 4 >2,435 118 1.32 (0.99‐1.77) >2,252
P‐trend 0.08
Carbohydrates (g/1000kcal*d)
Quartile 1 <98.6 113 1 (ref) <100.2
Quartile 2 98.6‐110.6 116 1.09 (0.83‐1.42) 100.2‐111.9
Quartile 3 110.7‐122.4 115 1.16 (0.87‐1.53) 112.0‐123.4
Quartile 4 >122.4 91 1.02 (0.75‐1.39) >123.4
P‐trend 0.78
Protein (g/1000kcal*d)
Quartile 1 <37.0 82 1 (ref) <37.7
Quartile 2 37.0‐41.6 104 1.01 (0.75‐1.36) 37.7‐42.4
Quartile 3 41.7‐46.9 123 1.04 (0.77‐1.40) 42.5‐47.7
Quartile 4 >46.9 126 1.02 (0.74‐1.39) >47.7
P‐trend 0.91
Fat (g/1000kcal*d)
Quartile 1 <34.4 79 1 (ref) <34.5
Quartile 2 34.4‐38.8 118 1.24 (0.93‐1.65) 34.5‐38.9
Quartile 3 38.9‐43.3 112 1.03 (0.76‐1.38) 38.9‐43.4
Quartile 4 >43.3 126 0.96 (0.71‐1.30) >43.4
P‐trend 0.43
Saturated fats (g/1000kcal*d)
Quartile 1 <12.5 89 1 (ref) <12.6
Quartile 2 12.5‐14.7 90 0.92 (0.68‐1.25) 12.6‐14.8
Quartile 3 14.8‐17.1 136 1.29 (0.97‐1.72) 14.9‐17.2
Quartile 4 >17.1 120 0.95 (0.70‐1.30) >17.2
P‐trend 0.93
Monounsaturated fats (g/1000kcal*d)
Quartile 1 <11.6 83 1 (ref) <11.4
Quartile 2 11.6‐13.4 104 1.04 (0.77‐1.39) 11.4‐13.2
Quartile 3 13.5‐16.0 126 1.06 (0.79‐1.41) 13.3‐15.7
Quartile 4 >16.0 122 0.85 (0.61‐1.20) >15.7
P‐trend 0.30
Polyunsaturated fats (g/1000kcal*d)
Quartile 1 <4.9 116 1 (ref) <5.0
Quartile 2 4.9‐6.0 104 0.90 (0.68‐1.19) 5.0‐6.1
Quartile 3 6.1‐7.6 109 0.90 (0.68‐1.20) 6.2‐7.7
Quartile 4 >7.6 106 0.83 (0.62‐1.12) >7.7
P‐trend 0.26
Starch (g/1000kcal*d)
Quartile 1 <47.9 105 1 (ref) <47.9




Quartile 3 57.3‐67.8 123 1.25 (0.96‐1.64) 57.2‐67.6
Quartile 4 >67.8 105 1.00 (0.75‐1.35) >67.6
P‐trend 0.80
Sugar (g/1000kcal*d)
Quartile 1 <38.9 115 1 (ref) <40.8
Quartile 2 38.9‐48.4 104 0.85 (0.65‐1.11) 40.8‐50.0
Quartile 3 48.5‐59.4 117 1.03 (0.79‐1.35) 50.1‐60.7
Quartile 4 >59.4 99 1.05 (0.78‐1.41) >60.7
P‐trend 0.48
Fiber (g/1000kcal*d)
Quartile 1 <9.1 112 1 (ref) <9.5
Quartile 2 9.1‐10.8 109 0.83 (0.64‐1.09) 9.5‐11.3
Quartile 3 10.9‐13.0 127 1.07 (0.81‐1.40) 11.4‐13.4
Quartile 4 >13.0 87 0.83 (0.61‐1.14) >13.4
P‐trend 0.50
Glycemic index (unit/d)
Quartile 1 <53.6 120 1 (ref) <53.3
Quartile 2 53.6‐56.0 117 1.24 (0.96‐1.60) 53.3‐55.7
Quartile 3 56.1‐58.5 90 0.98 (0.74‐1.30) 55.8‐58.3
Quartile 4 >58.5 108 1.07 (0.81‐1.41) >58.3
P‐trend 0.91
Glycemic load (unit/1000kcal*d)
Quartile 1 <54.4 114 1 (ref) <54.9
Quartile 2 54.4‐61.9 117 1.01 (0.78‐1.32) 54.9‐62.4
Quartile 3 62.0‐69.6 95 1.09 (0.82‐1.43) 62.5‐69.9





HR (95% CI) Intake HR (95% CI) Intake
102 1 (ref) <1,938 17 1 (ref) <1,636
102 0.95 (0.72‐1.26 1,938‐2,344 11 0.53 (0.24‐1.14) 1,636‐2,008
126 1.10 (0.84‐1.45 2,345‐2,808 18 0.86 (0.43‐1.72) 2,009‐2,464
169 1.25 (0.96‐1.63 >2,808 11 0.49 (0.22‐1.11) >2,464
0.038 0.19
145 1 (ref) <95.1 6 1 (ref) <99.3
142 1.10 (0.87‐1.41 95.1‐107.2 15 2.79 (1.02‐7.62) 99.3‐111.5
111 0.95 (0.73‐1.24 107.3‐119.8 15 3.03 (1.05‐8.75) 111.6‐123.1
101 0.97 (0.73‐1.29 >119.8 21 .15 (1.37‐15.22) >123.1
0.65 0.019
108 1 (ref) <35.5 13 1 (ref) <36.4
124 1.03 (0.79‐1.35 35.5‐39.8 18 1.19 (0.57‐2.49) 36.4‐41.1
129 1.02 (0.77‐1.34 39.9‐44.8 15 1.02 (0.46‐2.25) 41.2‐46.4
138 1.11 (0.84‐1.48 >44.8 11 0.92 (0.37‐2.29) >46.4
0.47 0.78
92 1 (ref) <34.2 17 1 (ref) <34.9
119 1.06 (0.81‐1.40 34.2‐38.6 15 0.94 (0.46‐1.94) 34.9‐39.2
142 1.11 (0.85‐1.46 38.7‐43.1 14 0.82 (0.39‐1.76) 39.3‐43.7
146 0.96 (0.72‐1.27 >43.1 11 0.55 (0.22‐1.38) >43.7
0.72 0.21
103 1 (ref) <12.1 16 1 (ref) <12.5
102 0.94 (0.71‐1.25 12.1‐14.4 14 1.06 (0.49‐2.28) 12.5‐14.7
148 1.26 (0.96‐1.64 14.5‐16.9 19 1.47 (0.67‐3.23) 14.8‐17.1
146 1.05 (0.79‐1.39 >16.9 8 0.59 (0.22‐1.62) >17.1
0.49 0.49
92 1 (ref) <12.0 9 1 (ref) <11.7
111 0.95 (0.72‐1.26 12.0‐13.9 12 1.19 (0.49‐2.90) 11.7‐13.6
147 1.02 (0.78‐1.34 14.0‐16.5 17 1.43 (0.60‐3.40) 13.7‐16.4
149 0.84 (0.62‐1.16 >16.5 19 1.25 (0.47‐3.39) >16.4
0.31 0.69
144 1 (ref) <4.7 20 1 (ref) >5.0
121 0.85 (0.66‐1.09 4.7‐5.7 13 0.87 (0.41‐1.86) 5.0‐6.2
121 0.82 (0.63‐1.06 5.8‐7.3 14 1.07 (0.48‐2.39) 6.3‐7.8
113 0.75 (0.57‐0.98 >7.3 10 0.72 (0.29‐1.77) >7.8
0.046 0.52
132 1 (ref) <47.9 8 1 (ref) <49.4




131 1.06 (0.82‐1.36 57.3‐68.4 15 1.82 (0.72‐4.58) 59.3‐69.9
112 0.85 (0.64‐1.11 >68.4 19 1.71 (0.63‐4.64) >69.9
0.27 0.46
150 1 (ref) <35.0 14 1 (ref) <38.6
112 0.80 (0.62‐1.02 35.0‐44.3 16 1.19 (0.58‐2.47) 38.6‐47.9
127 1.00 (0.78‐1.28 44.4‐55.6 11 0.96 (0.42‐2.18) 48.0‐58.7
110 1.02 (0.78‐1.34 >55.6 16 1.72 (0.77‐3.87) >58.7
0.57 0.25
150 1 (ref) <8.2 12 1 (ref) <9.0
130 0.89 (0.70‐1.13 8.2‐9.9 16 1.21 (0.56‐2.63) 9.0‐10.6
127 1.01 (0.79‐1.30 10.0‐11.8 17 1.39 (0.62‐3.09) 10.7‐12.8
92 0.87 (0.65‐1.16 >11.8 12 1.10 (0.44‐2.73) >12.8
0.54 0.81
138 1 (ref) <54.5 12 1 (ref) <53.8
131 1.13 (0.89‐1.44 54.5‐56.6 22 1.96 (0.96‐4.01) 53.8‐56.2
101 0.89 (0.68‐1.16 56.7‐59.0 12 1.16 (0.51‐2.64) 56.3‐58.7
129 1.00 (0.77‐1.29 >59.0 11 0.89 (0.35‐2.23) >58.7
0.72 0.65
122 1 (ref) <53.2 17 1 (ref) <54.9
110 0.93 (0.73‐1.18 53.2‐60.7 11 1.18 (0.49‐2.86) 54.9‐62.7
124 0.92 (0.71‐1.19 60.8‐68.7 13 1.74 (0.72‐4.21) 62.8‐70.3






60 1 (ref) <1,626 68 1 (ref)
72 1.11 (0.78‐1.57 1,626‐1,986 73 1.12 (0.80‐1.57)
68 1.03 (0.71‐1.48 1,987‐2,414 70 1.19 (0.85‐1.68)
76 1.31 (0.91‐1.89 >2,414 69 1.26 (0.87‐1.82)
0.17 0.21
74 1 (ref) <98.1 66 1 (ref)
93 1.28 (0.93‐1.77 98.1‐109.9 61 0.88 (0.62‐1.24)
61 1.03 (0.72‐1.48 110.0‐121.9 79 1.06 (0.75‐1.51)
48 0.99 (0.66‐1.48 >121.9 74 1.03 (0.71‐1.49)
0.78 0.68
46 1 (ref) <37.4 59 1 (ref)
64 1.15 (0.79‐1.66 37.4‐42.0 67 1.16 (0.81‐1.68)
87 1.03 (0.70‐1.52 42.1‐47.2 75 1.15 (0.79‐1.67)
79 0.99 (0.66‐1.49 >47.2 79 1.29 (0.88‐1.91)
0.75 0.22
43 1 (ref) <34.1 62 1 (ref)
64 1.11 (0.74‐1.66 34.1‐38.5 72 1.04 (0.74‐1.45)
85 1.23 (0.84‐1.82 38.6‐43.0 80 0.94 (0.67‐1.33)
84 1.13 (0.76‐1.69 >43.0 66 0.73 (0.50‐1.06)
0.56 0.07
53 1 (ref) <12.5 63 1 (ref)
64 1.19 (0.81‐1.73 12.5‐14.7 49 0.72 (0.49‐1.06)
75 1.30 (0.89‐1.90 14.8‐17.1 94 1.27 (0.90‐1.79)
84 1.19 (0.80‐1.77 >17.1 74 0.86 (0.59‐1.25)
0.43 0.92
42 1 (ref) <11.5 59 1 (ref)
68 1.03 (0.68‐1.54 11.5‐13.3 71 1.08 (0.77‐1.51)
80 1.27 (0.86‐1.87 13.4‐15.7 81 0.95 (0.67‐1.35)
86 1.02 (0.65‐1.59 >15.7 69 0.82 (0.54‐1.24)
0.93 0.25
78 1 (ref) >4.8 81 1 (ref)
68 0.89 (0.63‐1.26 4.8‐5.9 66 0.79 (0.57‐1.11)
66 0.75 (0.52‐1.08 6.0‐7.4 69 0.81 (0.58‐1.14)
64 0.84 (0.59‐1.20 >7.4 64 0.63 (0.44‐0.92)
0.38 0.024
76 1 (ref) <46.9 70 1 (ref)




70 1.32 (0.94‐1.86 55.9‐66.1 65 0.88 (0.63‐1.25)
51 0.86 (0.58‐1.27 >66.1 76 0.96 (0.67‐1.37)
0.54 0.67
78 1 (ref) <39.2 60 1 (ref)
68 0.78 (0.56‐1.08 39.2‐48.8 70 1.04 (0.73‐1.48)
70 0.98 (0.70‐1.36 48.9‐60.0 74 1.05 (0.73‐1.50)
60 0.99 (0.68‐1.44 >60.0 76 1.25 (0.87‐1.81)
0.81 0.21
71 1 (ref) <9.2 75 1 (ref)
65 0.78 (0.55‐1.09 9.2‐11.0 70 0.78 (0.56‐1.10)
85 1.14 (0.82‐1.59 11.1‐13.1 67 0.82 (0.57‐1.16)
55 0.77 (0.51‐1.15 >13.1 68 0.86 (0.59‐1.25)
0.51 0.59
86 1 (ref) <53.6 85 1 (ref)
71 1.15 (0.84‐1.58 53.6‐55.9 66 1.03 (0.75‐1.42)
58 0.85 (0.59‐1.20 56.0‐58.4 61 1.02 (0.72‐1.43)
61 0.84 (0.59‐1.20 >58.4 68 1.04 (0.73‐1.48)
0.20 0.84
77 1 (ref) <54.0 73 1 (ref)
74 1.23 (0.89‐1.68 54.0‐61.3 67 0.75 (0.53‐1.07)
64 0.92 (0.65‐1.32 61.4‐69.0 65 1.04 (0.75‐1.46)




Table 1. Baseline characteristics of participants in the EPIC study by onset of 
differentiated thyroid carcinoma (TC) at follow up and sex 
Characteristics 
Women   Men 
Non-cases 
(n=334,534) 
TC cases  
(n=499)   
Non-cases 
(n=142,184) 
TC cases     
(n=57) 
Country (%)           
  France 20.1 40.5    ―  ― 
  Italy 9.1 13.0   9.9 29.8 
  Spain 7.4 9.6   10.7 5.3 
  United Kingdom 15.7 5.0   16.1 7.0 
  The Netherlands 8.0 2.0   6.8 3.5 
  Greece 4.5 3.8   7.6 8.8 
  Germany 8.2 13.0   14.9 24.6 
  Sweden 7.9 3.8   15.7 8.8 
  Denmark 8.6 3.2   18.5 12.3 
  Norway 10.5 6.0    ―  ― 
Median age (27-75%) (years) 51.0 (44.9-57.5) 50.0 (45.8-55.9)   52.7 (45.7-59.6) 51.7 (44.7-58.2) 
Median BMI (25-75%) (kg/m2) 24.1 (21.9-27.2) 24.1 (22.0-27.3)   26.1 (24.0-28.6) 26.0 (24.3-27.7) 
Median alcohol (25-75%) (g/d) 3.3 (0.5-10.7) 2.9 (0.4-9.8)   12.5 (3.9-29.2) 12.1 (2.2-28.7) 
Never smokers (%)1 57.0 59.1   33.4 34.6 
Secondary education (%)1 70.5 68.6   65.4 68.5 
Physical inactivity (%)1 60.1 63.3   50.5 57.1 
Diabetes at baseline (%)1 2.4 1.9   4.0 3.6 
Menopause status and type (%)           
  Premenopausal 34.8 33.7    ―  ― 
  Perimenopausal 18.9 24.8    ―  ― 
  Natural menopause 43.4 36.1    ―  ― 
  Surgical menopause 2.9 5.4    ―  ― 
1Percentages were calculated among participants with available data 
 
Table 2. Hazard ratios (HR) and 95% confidence intervals for differentiated 
thyroid cancer according to quartile of intake of total energy, macronutrients, 
glycemic index and load in the EPIC study. 
      Thyroid carcinoma 
      No of 
cases
Model 1 Model 2 
    Intake HR (95% CI) HR (95% CI) 
Total energy (kcal/d)       
  Quartile 1 <1,630 128 1 (ref) 1 (ref) 
  Quartile 2 1,630-1,995 142 1.08 (0.85-1.38) 1.11 (0.87-1.42)
  Quartile 3 1,996-2,435 139 1.06 (0.82-1.36) 1.11 (0.86-1.43)
  Quartile 4 >2,435 147 1.18 (0.91-1.53) 1.29 (1.00-1.68)
  P-trend     0.23 0.06 
Carbohydrates (g/1000kcal*d)     
  Quartile 1 <98.6 143 1 (ref) 1 (ref) 
  Quartile 2 98.6-110.6 149 1.13 (0.90-1.43) 1.07 (0.84-1.35)
  Quartile 3 110.7-122.4 140 1.14 (0.89-1.45) 1.05 (0.82-1.35)
  Quartile 4 >122.4 124 1.12 (0.86-1.45) 1.01 (0.77-1.33)
  P-trend     0.39 0.93 
Protein (g/1000kcal*d)       
  Quartile 1 <37.0 104 1 (ref) 1 (ref) 
  Quartile 2 37.0-41.6 143 1.19 (0.92-1.54) 1.16 (0.89-1.50)
  Quartile 3 41.7-46.9 150 1.16 (0.89-1.51) 1.09 (0.84-1.43)
  Quartile 4 >46.9 159 1.24 (0.94-1.63) 1.14 (0.86-1.51)
  P-trend     0.18 0.51 
Fat (g/1000kcal*d)       
  Quartile 1 <34.4 108 1 (ref) 1 (ref) 
  Quartile 2 34.4-38.8 136 1.10 (0.85-1.41) 1.06 (0.82-1.37)
  Quartile 3 38.9-43.3 154 1.12 (0.87-1.44) 1.05 (0.82-1.36)
  Quartile 4 >43.3 158 0.98 (0.76-1.28) 0.90 (0.69-1.18)
  P-trend     0.82 0.38 
Saturated fats (g/1000kcal*d)     
  Quartile 1 <12.5 115 1 (ref) 1 (ref) 
  Quartile 2 12.5-14.7 114 0.95 (0.73-1.24) 0.93 (0.71-1.21)
  Quartile 3 14.8-17.1 170 1.34 (1.04-1.73) 1.29 (1.00-1.66)
  Quartile 4 >17.1 157 1.07 (0.82-1.40) 1.01 (0.77-1.32)
  P-trend     0.34 0.63 
Monounsaturated fats (g/1000kcal*d)    
  Quartile 1 <11.6 103 1 (ref) 1 (ref) 
  Quartile 2 11.6-13.4 131 1.07 (0.82-1.40) 1.05 (0.81-1.36)
  Quartile 3 13.5-16.0 162 1.13 (0.87-1.46) 1.09 (0.84-1.41)
  Quartile 4 >16.0 160 0.96 (0.71-1.30) 0.90 (0.67-1.22)
  P-trend     0.72 0.44 
Polyunsaturated fats (g/1000kcal*d)     
  Quartile 1 <4.9 159 1 (ref) 1 (ref) 
  Quartile 2 4.9-6.0 135 0.86 (0.68-1.09) 0.84 (0.66-1.07)
  Quartile 3 6.1-7.6 132 0.81 (0.63-1.04) 0.78 (0.61-1.00)
  Quartile 4 >7.6 130 0.78 (0.60-1.01) 0.74 (0.57-0.95)
  P-trend     0.07 0.028 
Starch (g/1000kcal*d)       
  Quartile 1 <47.9 140 1 (ref) 1 (ref) 
  Quartile 2 47.9-57.2 140 1.12 (0.89-1.42) 1.09 (0.86-1.38)
  Quartile 3 57.3-67.8 145 1.14 (0.90-1.44) 1.09 (0.86-1.39)
  Quartile 4 >67.8 131 0.97 (0.75-1.25) 0.91 (0.70-1.18)
  P-trend     0.82 0.47 
Sugar (g/1000kcal*d)       
  Quartile 1 <38.9 142 1 (ref) 1 (ref) 
  Quartile 2 38.9-48.4 135 0.91 (0.72-1.16) 0.89 (0.70-1.13)
  Quartile 3 48.5-59.4 143 1.04 (0.82-1.31) 1.00 (0.78-1.27)
  Quartile 4 >59.4 136 1.17 (0.91-1.51) 1.11 (0.85-1.43)
  P-trend     0.14 0.31 
Fiber (g/1000kcal*d)       
  Quartile 1 <9.1 148 1 (ref) 1 (ref) 
  Quartile 2 9.1-10.8 135 0.83 (0.65-1.05) 0.78 (0.62-1.00)
  Quartile 3 10.9-13.0 155 1.05 (0.83-1.32) 0.97 (0.76-1.24)
  Quartile 4 >13.0 118 0.91 (0.70-1.18) 0.83 (0.63-1.09)
  P-trend     0.83 0.41 
Glycemic index (unit/d)       
  Quartile 1 <53.6 166 1 (ref) 1 (ref) 
  Quartile 2 53.6-56.0 144 1.09 (0.87-1.37) 1.09 (0.87-1.37)
  Quartile 3 56.1-58.5 117 0.93-0.73-1.18) 0.93 (0.73-1.19)
  Quartile 4 >58.5 129 0.94 (0.73-1.20) 0.94 (0.73-1.20)
  P-trend     0.47 0.46 
Glycemic load (unit/1000kcal*d)     
  Quartile 1 <54.4 152 1 (ref) 1 (ref) 
  Quartile 2 54.4-61.9 141 1.02 (0.81-1.29) 0.98 (0.77-1.23)
  Quartile 3 62.0-69.6 123 1.06 (0.83-1.34) 0.99 (0.77-1.26)
  Quartile 4 >69.6 140 1.04 (0.81-1.34) 0.95 (0.74-1.24)
  P-trend     0.72 0.77 
Model 1: Cox model stratified by center, age at baseline, and sex 
Model 2: Additionally adjusted for body mass index, smoking status, education, 
physical activity, total energy (as appropriate) and alcohol intake, and, in 
women, for menopausal status and type.  
 
Table 3. Hazard ratios (HR) and 95% confidence intervals for differentiated thyroid carcinoma stratified by body mass index (BMI) 
according to intake of total energy and carbohydrate-related dietary variables in the EPIC study 
      Body mass index <25     Body mass index ≥25 
P for 
heterogeneity         No of 
cases 
Model 2        No of 
cases 
Model 2 
      Intake  HR (95% CI)     Intake  HR (95% CI) 
Total energy (kcal/d)                      
   Quartile 1  <1,625  74  1 (ref)     <1,636  55  1 (ref)    
   Quartile 2  1,625‐1,979  76  0.97 (0.70‐1.34)     1,636‐2,015  70  1.36 (0.95‐1.96)    
   Quartile 3  1,980‐2,396  69  0.85 (0.61‐1.20)     2,016‐2,479  63  1.27 (0.87‐1.86)    
   Quartile 4  >2,396  90  1.09 (0.78‐1.51)     >2,479  59  1.35 (0.90‐2.02)    
   P‐trend        0.65           0.24  0.31 
Carbohydrates (g/1000kcal*d)                   
   Quartile 1  <100.7  90  1 (ref)     <38.6  56  1 (ref)    
   Quartile 2  100.7‐112.4  86  1.18 (0.87‐1.60)     38.6‐43.4  63  1.16 (0.81‐1.68)    
   Quartile 3  112.5‐123.9  73  1.12 (0.81‐1.55)     43.5‐48.3  63  1.19 (0.81‐1.75)    
   Quartile 4  >123.9  60  1.06 (0.75‐1.51)     >48.3  65  1.35 (0.91‐2.01)    
   P‐trend        0.70           0.15  0.17 
Starch (g/1000kcal*d)                      
   Quartile 1  <48.6  97  1 (ref)     <47.1  49  1 (ref)    
   Quartile 2  48.6‐58.0  82  0.99 (0.73‐1.34)     47.1‐56.3  53  1.20 (0.81‐1.77)    
   Quartile 3  58.1‐68.5  71  0.85 (0.62‐1.16)     56.4‐67.1  74  1.68 (1.15‐2.44)    
   Quartile 4  >68.5  59  0.65 (0.46‐0.93)     >67.1  71  1.52 (1.02‐2.28)    
   P‐trend        0.014           0.020  <0.001 
Sugar (g/1000kcal*d)                      
   Quartile 1  <40.5  78  1 (ref)     <37.3  72  1 (ref)    
   Quartile 2  40.5‐49.9  70  0.94 (0.68‐1.30)     37.3‐46.8  54  0.71 (0.50‐1.02)    
   Quartile 3  50.0‐60.6  79  1.18 (0.85‐1.62)     46.9‐58.0  68  0.95 (0.67‐1.34)    
   Quartile 4  >60.6  82  1.61 (1.16‐2.24)     >58.0  53  0.76 (0.51‐1.12)    
   P‐trend        0.002           0.34  0.005 
Fiber (g/1000kcal*d)                      
   Quartile 1  <9.2  83  1 (ref)     <9.0  63  1 (ref)    
   Quartile 2  9.2‐10.9  84  0.96 (0.70‐1.31)     9.0‐10.8  51  0.71 (0.49‐1.04)    
   Quartile 3  11.0‐13.1  81  1.11 (0.80‐1.53)     10.9‐12.9  78  1.10 (0.77‐1.58)    
   Quartile 4  >13.1  61  1.07 (0.74‐1.53)     >12.9  55  0.77 (0.51‐1.15)    
   P‐trend        0.58           0.50  0.24 
Glycemic index (unit/d)                      
   Quartile 1  <53.7  109  1 (ref)     <53.5  61  1 (ref)    
   Quartile 2  53.7‐56.1  76  0.84 (0.63‐1.13)     53.5‐55.9  60  1.34 (0.93‐1.93)    
   Quartile 3  56.2‐58.6  58  0.65 (0.46‐0.90)     56.0‐58.4  65  1.63 (1.13‐2.35)    
   Quartile 4  >58.6  66  0.64 (0.46‐0.89)     >58.4  61  1.54 (1.05‐2.28)    
   P‐trend        0.003           0.014  <0.001 
Glycemic load (unit/1000kcal*d)                   
   Quartile 1  <55.6  79  1 (ref)     <95.7  71  1 (ref)    
   Quartile 2  55.6‐63.1  88  1.09 (0.81‐1.47)     95.7‐120.7  51  1.27 (0.88‐1.83)    
   Quartile 3  63.2‐70.6  68  0.91 (0.66‐1.27)     120.8‐151.7  62  1.38 (0.95‐2.01)    
   Quartile 4  >70.6  74  0.97 (0.69‐1.37)     >151.7  63  1.37 (0.92‐2.04)    
   P‐trend        0.70           0.11  0.29 
Model 2: Cox model stratified by center, age at baseline, and sex, and adjusted for BMI, total energy (as appropriate) and alcohol intake, 
smoking status, education, physical activity, and, in women menopausal status and type. 
 
